dantrolene has been researched along with Dystonic Disorders in 2 studies
Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.
Dystonic Disorders: Acquired and inherited conditions that feature DYSTONIA as a primary manifestation of disease. These disorders are generally divided into generalized dystonias (e.g., dystonia musculorum deformans) and focal dystonias (e.g., writer's cramp). They are also classified by patterns of inheritance and by age of onset.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This paper reviews the various therapeutic options available for childhood-onset dystonia, with a specific attention to dosage and side effects of the drugs regarding pediatric population according to the data of the literature." | 2.46 | [Treatment of childhood dystonia]. ( Bahi-Buisson, N; Doummar, D; Echenne, B; Payet, C; Roubertie, A; Roze, E, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roubertie, A | 1 |
| Roze, E | 1 |
| Bahi-Buisson, N | 1 |
| Payet, C | 1 |
| Echenne, B | 1 |
| Doummar, D | 1 |
| Linazasoro, G | 1 |
| Van Blercom, N | 1 |
| Castro, A | 1 |
| Dapena, MD | 1 |
1 review available for dantrolene and Dystonic Disorders
| Article | Year |
|---|---|
[Treatment of childhood dystonia].
Topics: Algorithms; Anticonvulsants; Benzodiazepines; Botulinum Toxins, Type A; Child; Cholinergic Antagonis | 2010 |
1 other study available for dantrolene and Dystonic Disorders
| Article | Year |
|---|---|
Subthalamic deep brain stimulation masking possible malignant syndrome in Parkinson disease.
Topics: Analgesics, Non-Narcotic; Anti-Infective Agents; Antiparkinson Agents; Combined Modality Therapy; Co | 2004 |